Zylox-Tonbridge (02190) Announces Monthly Return with Unchanged Share Capital for February 2026

Bulletin Express03-03 17:06

Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13 million shares. This figure includes 336.35 million H shares and 7.78 million domestic shares, both with a par value of RMB 1.

As of month-end, issued H shares stood at 336.35 million in total, comprising 329.50 million shares in issue (excluding treasury shares) and 6.85 million treasury shares. The company notes that its public float requirement of 25% for H shares has been met. Meanwhile, domestic shares amount to 7.78 million, with no changes recorded during the reporting period.

Zylox-Tonbridge also reports that up to 0.86 million H shares may be issued or transferred out of treasury under a share award scheme adopted on 19 December 2024. No other agreements or arrangements were disclosed for issuing additional shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180827270?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180827270","market":"hk","top_or_hot":-1,"title":"Zylox-Tonbridge (02190) Announces Monthly Return with Unchanged Share Capital for February 2026","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13 million shares. This figure includes 336.35 million H shares and 7.78 million domestic shares, both with a par value of RMB 1.</p>\n<p>As of month-end, issued H shares stood at 336.35 million in total, comprising 329.50 million shares in issue (excluding treasury shares) and 6.85 million treasury shares. The company notes that its public float requirement of 25% for H shares has been met. Meanwhile, domestic shares amount to 7.78 million, with no changes recorded during the reporting period.</p>\n<p>Zylox-Tonbridge also reports that up to 0.86 million H shares may be issued or transferred out of treasury under a share award scheme adopted on 19 December 2024. No other agreements or arrangements were disclosed for issuing additional shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge (02190) Announces Monthly Return with Unchanged Share Capital for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge (02190) Announces Monthly Return with Unchanged Share Capital for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-03 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13 million shares. This figure includes 336.35 million H shares and 7.78 million domestic shares, both with a par value of RMB 1.</p>\n<p>As of month-end, issued H shares stood at 336.35 million in total, comprising 329.50 million shares in issue (excluding treasury shares) and 6.85 million treasury shares. The company notes that its public float requirement of 25% for H shares has been met. Meanwhile, domestic shares amount to 7.78 million, with no changes recorded during the reporting period.</p>\n<p>Zylox-Tonbridge also reports that up to 0.86 million H shares may be issued or transferred out of treasury under a share award scheme adopted on 19 December 2024. No other agreements or arrangements were disclosed for issuing additional shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1180827270","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180827270","pubTimestamp":1772528791,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"归乐通桥(02190)公布2026年2月股本不变月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13 million shares. This figure includes 336.35 million H shares and 7.78 million domestic shares, both with a par value of RMB 1.\nAs of month-end, issued H shares stood at 336.35 million in total, comprising 329.50 million shares in issue (excluding treasury shares) and 6.85 million treasury shares. The company notes that its public float requirement of 25% for H shares has been met. Meanwhile, domestic shares amount to 7.78 million, with no changes recorded during the reporting period.\nZylox-Tonbridge also reports that up to 0.86 million H shares may be issued or transferred out of treasury under a share award scheme adopted on 19 December 2024. No other agreements or arrangements were disclosed for issuing additional shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180827270","isCrawlerRequest":true}